Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery (EVERS)

Centre Hospitalier Universitaire de Besancon

Status

Enrolling

Conditions

Acoustic Neuroma

Vestibular Schwannoma

Neurinoma, Acoustic

Treatments

Other: Vestibular exam

Study type

Interventional

Funder types

Other

Identifiers

NCT06112509

2023/823

Details and patient eligibility

About

The purpose of this study is to evaluate the vestibular effects of gamma-knife radiosurgery, as part of the treatment of vestibular schwannoma.

Full description

Vestibular schwannoma is a benign tumor located on the vestibulocochlear nerve. It represents 6 to 8% of intracranial tumors, 80% of ponto-cerebral angle tumors and its frequency is 13 cases per million inhabitants per year.

The main symptoms related to the development of vestibular schwannoma are unilateral deafness of perception, unilateral tinnitus, unilateral vestibular deficit vertigo, facial paralysis.

Management is divided into 3 options: monitoring, surgery and gamma-knife radiosurgery.

This study will focus on gamma-knife radiosurgery. The objective of this treatment is to stabilize the evolution of schwannoma.

This study aims to describe the vestibular effects of radiosurgery.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria :

Men and women aged 18 to 90 included
Subject who benefited from gamma-knife radiosurgery as part of the treatment of vestibular schwannoma
Non-opposition of the subject to participate in the study
Affiliation to a French social security scheme or beneficiary of such a scheme

Exclusion Criteria :

Subject with another vestibular pathology
Subject who did not benefit from a vestibular assessment before treatment with gamma-knife radiosurgery
Legal incapacity or limited legal capacity
Subject unlikely to cooperate in the study and/or weak cooperation anticipated by the investigator
Subject without health insurance
Subject being in the period of exclusion from another study or provided for by the "national volunteer file".